secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001683168-26-000877
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health enters $50M equity line with Tumim Stone Capital; pre-funded warrant issued
--------------------------------------------------------------------------------

- Common Stock Purchase Agreement allows Tivic to sell up to $50M of common stock to Tumim Stone Capital at 97% or 95% of VWAP.
- Pre-funded warrant for 437,012 shares at $0.0001 per share issued as commitment fee; warrants exercisable immediately.
- Exchange Cap set at 506,848 shares (19.99% of outstanding) unless average sale price equals or exceeds $1.02 per share.
- Daily maximum draw is $1M (one-day valuation) or $2.5M (three-day valuation) with volume limits of 15% or 40% of daily volume.
- Registration Rights Agreement filed to register resale of shares issued under the Purchase Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826000877/0001683168-26-000877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826000877/tivic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer